filmarray gastrointestinal panel fgp (BioFire Defense)
Structured Review
Filmarray Gastrointestinal Panel Fgp, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/filmarray+gastrointestinal+panel+(fgp/filmarray+gastrointestinal+panel/pm36447381-32-0-3
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: 2358. Understanding the Clinical Implications of Clostridium difficile Detection in the Molecular Age: Colonization vs. Infection in Children Less Than 3 Years of Age Article Snippet: Symptomatic patients < 3 years old with CD detected by the Article Title: Clinical impact of biofire gastrointestinal panel testing for hospitalised children with acute gastroenteritis. Article Snippet: Amongst children in the United States, acute gastroenteritis accounts for >1.5 million outpatient visits, 200 000 hospitalizations and ~300 deaths per year.1 During the past few years, there has been a trend towards moving from the traditional methods for stool testing to employing a multiplexpolymerase chain reaction (PCR) technique for detecting enteric pathogens, that is, the BioFire FilmArray Gastrointestinal Panel (FGP), which can detect 22 different enteric pathogens, increase the detection of infectious pathogens and shorten the time to result.2 In a prospective study reporting on 1089 diarrhoeal episodes in children, bacteria were detected by the FGP in 27% of the episodes versus 5% by conventional cultures.3 Previous studies have suggested that by using the FGP instead of conventional methods, the length of isolation,4 days of antibiotic treatment,4– 6 and length of hospitalisation (LOH) can Received: 24 August 2022 | Revised: 30 October 2022 | Accepted: 28 November 2022 DOI: 10.1111/apa.16610 |
